Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H101 for Refractory Malignant Ascites
NCT04771676Phase 2Completed
- Sponsor
- Fudan University
- Start
- Mar 2021
- Primary completion
- Jan 2023
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of Oncorine in malignant ascites, sponsored by Fudan University. Started Mar 2021; status: completed.
02
Drugs
Oncorine
03
Conditions
malignant ascites
Beyond the preview
Go deeper on NCT04771676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771676.